Answers are grounded in this paper and cite their sources.
The widespread occurrence of pharmaceutical compounds in aquatic environments is a major environmental concern, due to their persistence, potential toxicity, and increasing detection in surface waters. Traditional wastewater treatment plants are often not equipped to effectively remove these compounds, leading to their accumulation in water bodies and subsequent risks to aquatic ecosystems and human health. This research aims to explore the application of photocatalytic degradation as a sustainable and efficient method to remove pharmaceutical residues from wastewater. Photocatalysis, an advanced oxidation process, utilises semiconductor catalysts activated by light to generate reactive species capable of breaking down complex pharmaceutical molecules into non-toxic by-products. The results demonstrate that photocatalysis, especially when using modified titanium dioxide (TiO2) and visible-light-responsive catalysts, can achieve significant removal of commonly found pharmaceutical pollutants such as diclofenac, carbamazepine, and ibuprofen. This research concludes that photocatalytic treatment holds promise as a viable addition to conventional wastewater systems, offering an environmentally friendly solution without producing harmful secondary pollutants. However, limitations include the need for optimised catalyst recovery, energy input under natural conditions, and scalability for full-scale implementation. The study emphasises the necessity of integrating advanced treatment technologies like photocatalysis with policy frameworks for pharmaceutical waste control.
No takes yet. Share an insight, caveat, or question.
Vadiraj et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: